DIVISLABNSEDivi's Laboratories Limited· PharmaceuticalsMinimalNeutral
Announced Tue, 30 Sept · 08:49 IST

Divi's Laboratories Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

DIVISLAB · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Divi's Laboratories has informed the stock exchanges that the trading window for company insiders will be closed from October 1, 2025 until 48 hours after the declaration of unaudited financial results for Q2 and H1 FY26 (quarter and half year ending September 30, 2025). This is a mandatory compliance filing under SEBI's insider trading regulations. The date of the board meeting to approve these results has not yet been disclosed and will be communicated later. The closure prevents designated persons and their immediate relatives from trading in the company's shares during this sensitive period.

Likely market impact

This is a routine regulatory filing and does not affect the stock price directly. However, it signals that Divi's Labs Q2 FY26 earnings results are expected to be announced in the coming weeks, which investors should watch for as a potential catalyst.